Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>Products>This Product

IsoCyte Laser Scanning Cytometer

Product Description

"Experience the benefit of multiplexed, cell- and bead-based assays performed during high content screening in a high throughput screening environment, ensuring heterogeneous responses can be captured earlier in the research and discovery of new therapeutics.
Now multiplexed, homogeneous, bead and cell-based assays become easy to develop and run as robust primary screens. The cytometer can scan a plate in as little as 3 minutes, regardless of cell- or well-density while resolving objects at micron resolution in four colors simultaneously. These fast scan times and whole well analysis can gather data from >150,000 wells per 8-hour day, achieving the acquisition rates expected of high-throughput screening. The cytometer's speed comes from unique design elements including a large depth of focus and large field of view which eliminates the requirements to periodically focus or acquire multiple exposures to cover an entire field of view. A light scatter (labe free) mode allows generation of data from non-fluorescent objects (e.g., stem cell colonies where addition of dyes is unacceptable).

To help simplify the workflow of moving suspension cytometry assays into the screening environment, the IsoCyte Cytometer leverages a microplate-based environment to streamline evaluation of both adherent and suspension cell types, eliminating separation steps for adherent cells or colonies while eradicating daily routine procedures to prime and clean fluid lines. This well-based environment utilizes small aliquots (384- or 1536-well plates), preserving valuable stem or primary cells.  See the poster ""High-Throughput Multiplexed Assay for Analysis of Hematopoietic Stem Cells Differentiation and Hematopoietic Toxicity"".  Additionally, a microplate based assay allows samples to be rescanned to confirm results or gather additional content at a higher magnification on other systems."

Product IsoCyte Laser Scanning Cytometer
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439

Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Rare Immunodeficiency Yields Unexpected Insights
Scientists uncover previously unknown gene mutation revealing the role of a key molecule involved in immune cell development.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Precision Medicine Guiding Cancer Patients’ Chemotherapy Decision
New study finds doctors use genetic test to measure breast cancer recurrence risk, make tailored treatment recommendations.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
Genetic Signature Linked to Cancer Prognosis Identified
The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos